International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trial.
about
Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now?Posttransplant Lymphoproliferative Disorder: Otolaryngological Manifestations and Management.HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3.Infusions of Epstein-Barr virus-specific cytotoxic T lymphocytes as post-remission therapy in high-risk post-transplant lymphoproliferative disorder patients: report of two cases.Comprehensive review of post-organ transplant hematologic cancers.[Progress due to networking structures. Challenges for the Competence Network Malignant Lymphomas in the Era of Precision Medicine].
P2860
International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
International prognostic index ...... : clues from the PTLD-1 trial.
@en
International prognostic index ...... : clues from the PTLD-1 trial.
@nl
type
label
International prognostic index ...... : clues from the PTLD-1 trial.
@en
International prognostic index ...... : clues from the PTLD-1 trial.
@nl
prefLabel
International prognostic index ...... : clues from the PTLD-1 trial.
@en
International prognostic index ...... : clues from the PTLD-1 trial.
@nl
P2093
P2860
P50
P356
P1476
International prognostic index ...... D: clues from the PTLD-1 trial
@en
P2093
D Dierickx
F Morschhauser
German PTLD Study Group and the European PTLD Network
H Lehmkuhl
I Anagnostopoulos
J M Zaucha
P2860
P304
P356
10.1111/AJT.13086
P407
P577
2015-03-03T00:00:00Z